30 years on, CANTAB inventors herald the dawn of a new era in neuroscience

Posted on 7 October 2015

Three decades ago two emerging neuroscientists, Barbara Sahakian and Trevor Robbins from University of Cambridge received a grant to fund their development of the Cambridge Neuropsychological Automated Test Battery or CANTAB™. 

Read on

Shaping the future of drug development

Posted on 1 October 2015

From the 8th – 11th October leading scientists and decision-makers in pharma, biotech, clinical sites, and service companies will come together in Boca Raton in Florida for the 6th CNS Summit to shape the future of drug development.

Read on

Addiction: From Biology to Recovery

Posted on 30 September 2015

Cambridge Cognition will be attending the 17th annual International Society of Addiction Medicine Congress in Dundee from the 5th – 8th October 2015.

Read on

WEBINAR: Leveraging Cognitive Measures in Clinical Trials

Posted on 25 September 2015

This webinar will discuss the assessment of cognitive function throughout the development of drugs for both CNS and non-CNS indications. It will include a discussion of methodological considerations for the design of clinical trials and approaches to the analysis and interpretation of cognitive outcome measures for the evaluation of both drug efficacy and safety

Read on